N. Brownell and C. Kumtornrut, “Cutaneous hyperpigmentation induced by daclatasvir, sofosbuvir, and ribavirin combination therapy”, Thai J Dermatol, vol. 33, no. 2, pp. 173–179, Jun. 2017.